AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $129,790,000 | -68.2% | 180,790 | 0.0% | 0.00% | – |
Q4 2021 | $408,585,000 | -18.5% | 180,790 | +3.8% | 0.00% | – |
Q3 2021 | $501,619,000 | -33.4% | 174,173 | -12.4% | 0.00% | – |
Q2 2021 | $753,224,000 | +138.2% | 198,740 | +112.7% | 0.00% | – |
Q1 2021 | $316,220,000 | +28.2% | 93,418 | +6.1% | 0.00% | – |
Q4 2020 | $246,624,000 | +11.6% | 88,080 | 0.0% | 0.00% | – |
Q3 2020 | $221,081,000 | -81.7% | 88,080 | -1.2% | 0.00% | -100.0% |
Q2 2020 | $1,211,160,000 | +101.9% | 89,187 | +12.7% | 0.00% | – |
Q1 2020 | $599,797,000 | +13.7% | 79,129 | -5.2% | 0.00% | – |
Q4 2019 | $527,588,000 | +67.6% | 83,479 | +3.9% | 0.00% | – |
Q3 2019 | $314,811,000 | -13.1% | 80,309 | +7.3% | 0.00% | – |
Q2 2019 | $362,182,000 | -30.4% | 74,831 | +17.8% | 0.00% | – |
Q1 2019 | $520,212,000 | +131.1% | 63,518 | +56.0% | 0.00% | – |
Q4 2018 | $225,137,000 | +43.2% | 40,712 | +128.7% | 0.00% | – |
Q3 2018 | $157,174,000 | -11.5% | 17,800 | 0.0% | 0.00% | – |
Q2 2018 | $177,644,000 | +4.7% | 17,800 | 0.0% | 0.00% | – |
Q1 2018 | $169,634,000 | – | 17,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
Leap Investments LP | 54,700 | $415,000 | 0.61% |